Clinical Trial Update: Prospective, Observational Study in Sickle Cell Disease Patients on Crizanlizumab Treatment in Middle East Countries and India

View source ↗

Summary

This document notes the termination of a prospective, observational study evaluating crizanlizumab in sickle cell disease patients in Middle East countries and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• ADAKVEO (crizanlizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Sickle Cell Disease | Status: TERMINATED